Drug Research
Drug Development Technology Leader ArisGlobal Completes Acquisition of Amplexor Life Sciences
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, announces the completion of its acquisition of Amplexor Life Sciences. This deal will deliver the most intelligent, connected,...
News
How To Prevent And Deal With Pharmaceutical Injuries
Millions worldwide rely on prescription and over-the-counter medications daily to manage their health conditions, alleviate their pain, or simply feel better. While these medications can be lifesaving and beneficial, they can pose serious risks if not used correctly or...
Drug Research
Mixed Modified Antibodies Have Potency Against SARS-CoV-2
It is indeed possible to enhance the antibodies that the body goes on to produce so as to fight SARS-CoV2. In a study conducted by Lund University researchers in Sweden, this was inferred by redesigning the antibodies as well...
Clinical Trials
Birmingham University Forms Alliance On Gestational Diabetes
The University of Birmingham in the UK has entered into a collaboration with Dexter and Cagedim Health Data in order to conduct the RADIANT trial, which focuses on gestational diabetes mellitus.
The trial will make use of a new approach...
Drug Research
FDA New Drug Office Underlines Research Projects For Growth
In 2018, the FDA’s Centre for Drug Evaluation and Research’s Office of New Drugs- OND went on to develop a new programme so as to centralise as well as enhance the regulatory science research actions. More recently, the OND...
Drug Research
Ingestible Dose By Singapore For Real-Time Radiation Track
A novel discovery by the researchers at the National University of Singapore can go on to aid in the treatment of gastric cancer by improving the radiotherapy precision, which is mostly used in combination with treatment options ranging from...
BioPharma
Biopharma Spectrum To Be Driven By Automation In Next Decade
One of the reports concerning automation in the biopharmaceutical sector has gone on to show that the market is estimated to grow at a CAGR of 5.7% during the forecast period of 2023–2033. According to the data, the market’s...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read